BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

267 related articles for article (PubMed ID: 33890875)

  • 1. BIA-ALCL and Textured Breast Implants: A Systematic Review of Evidence Supporting Surgical Risk Management Strategies.
    Nelson JA; McCarthy C; Dabic S; Polanco T; Chilov M; Mehrara BJ; Disa JJ
    Plast Reconstr Surg; 2021 May; 147(5S):7S-13S. PubMed ID: 33890875
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Risk of breast implant associated anaplastic large cell lymphoma (BIA-ALCL) in a cohort of 3546 women prospectively followed long term after reconstruction with textured breast implants.
    Cordeiro PG; Ghione P; Ni A; Hu Q; Ganesan N; Galasso N; Dogan A; Horwitz SM
    J Plast Reconstr Aesthet Surg; 2020 May; 73(5):841-846. PubMed ID: 32008941
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Management of Symptomatic Patients with Textured Implants.
    Asaad M; Offodile AC; Santanelli Di Pompeo F; Bevers TB; Stelly S; Carew LA; Barnea Y; Miranda RN; Butler CE; Clemens MW
    Plast Reconstr Surg; 2021 May; 147(5S):58S-68S. PubMed ID: 33890882
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Breast implant-associated anaplastic large cell lymphoma: A comprehensive review.
    Marra A; Viale G; Pileri SA; Pravettoni G; Viale G; De Lorenzi F; Nolè F; Veronesi P; Curigliano G
    Cancer Treat Rev; 2020 Mar; 84():101963. PubMed ID: 31958739
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Applying Principles of Breast Revision to Managing Aesthetic Patients with Textured Implants.
    Gabriel A; O'Rorke E; Maxwell GP
    Plast Reconstr Surg; 2021 May; 147(5S):24S-30S. PubMed ID: 33890877
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Breast Implant-associated Anaplastic Large Cell Lymphoma Incidence: Determining an Accurate Risk.
    Nelson JA; Dabic S; Mehrara BJ; Cordeiro PG; Disa JJ; Pusic AL; Matros E; Dayan JH; Allen RJ; Coriddi M; Polanco TO; Shamsunder MG; Wiser I; Morrow M; Dogan A; Cavalli MR; Encarnacion E; Lee ME; McCarthy CM
    Ann Surg; 2020 Sep; 272(3):403-409. PubMed ID: 32694446
    [TBL] [Abstract][Full Text] [Related]  

  • 7. An Unusual Case of BIA-ALCL Associated with Prolonged/Complicated Biocell-Textured Expander, followed by Smooth Round Breast Implant Exposure, and Concurrent Use of Adalimumab.
    Akhavan AA; Wirtz EC; Ollila DW; Bhatt N
    Plast Reconstr Surg; 2021 Aug; 148(2):299-303. PubMed ID: 34133406
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Breast Reconstruction Following Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Lamaris GA; Butler CE; Deva AK; Miranda RN; Hunt KK; Connell T; Lipa JE; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):51S-58S. PubMed ID: 30817556
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Current Risk Estimate of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Textured Breast Implants.
    Collett DJ; Rakhorst H; Lennox P; Magnusson M; Cooter R; Deva AK
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):30S-40S. PubMed ID: 30817554
    [TBL] [Abstract][Full Text] [Related]  

  • 10. EUSOMA position regarding breast implant associated anaplastic large cell lymphoma (BIA-ALCL) and the use of textured implants.
    Cardoso MJ; Wyld L; Rubio IT; Leidenius M; Curigliano G; Cutuli B; Marotti L; Biganzoli L
    Breast; 2019 Apr; 44():90-93. PubMed ID: 30703669
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Risk of Breast Implant-Associated Anaplastic Large Cell Lymphoma in Patients with Textured Tissue Expanders.
    Nelson JA; McKernan CD; Rubenstein RN; Shamsunder MG; Poulton R; Dabic S; Mehrara BJ; Disa JJ; Cordeiro PG; McCarthy CM
    Plast Reconstr Surg; 2023 Jul; 152(1):32-37. PubMed ID: 36728202
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A Prospective Approach to Inform and Treat 1340 Patients at Risk for BIA-ALCL.
    Roberts JM; Carr LW; Jones A; Schilling A; Mackay DR; Potochny JD
    Plast Reconstr Surg; 2019 Jul; 144(1):46-54. PubMed ID: 31246798
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Smooth Versus Textured Tissue Expander Breast Reconstruction: Complications and Efficacy.
    McLaughlin C; Hughes AJ; Parham CS; Fritsche M; Potochny JD; Kunselman A; Ravnic DJ
    Ann Plast Surg; 2022 May; 88(3 Suppl 3):S288-S292. PubMed ID: 35513333
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Breast implant associated anaplastic large cell lymphoma: The UK experience. Recommendations on its management and implications for informed consent.
    Johnson L; O'Donoghue JM; McLean N; Turton P; Khan AA; Turner SD; Lennard A; Collis N; Butterworth M; Gui G; Bristol J; Hurren J; Smith S; Grover K; Spyrou G; Krupa K; Azmy IA; Young IE; Staiano JJ; Khalil H; MacNeill FA
    Eur J Surg Oncol; 2017 Aug; 43(8):1393-1401. PubMed ID: 28596034
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Complication Profiles of Smooth vs Textured Tissue Expanders in Breast Reconstruction: A Systematic Review and Meta-Analysis.
    Fijany AJ; Chaker SC; Hung YC; Zago I; Friedlich N; Olsson SE; Holan CA; Montorfano L; Mubang RN; Givechian KB; Boctor MJ; Pekarev M; Martinez-Jorge J; Slater ED
    Aesthet Surg J; 2024 Mar; 44(4):383-393. PubMed ID: 37757895
    [TBL] [Abstract][Full Text] [Related]  

  • 16. U.S. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma.
    Doren EL; Miranda RN; Selber JC; Garvey PB; Liu J; Medeiros LJ; Butler CE; Clemens MW
    Plast Reconstr Surg; 2017 May; 139(5):1042-1050. PubMed ID: 28157769
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Is Banning Texturized Implants to Prevent Breast Implant-Associated Anaplastic Large Cell Lymphoma a Rational Decision? A Meta-Analysis and Cost-Effectiveness Study.
    Danilla SV; Jara RP; Miranda F; Bencina F; Aguirre M; Troncoso E; Erazo CA; Andrades PR; Sepulveda SL; Albornoz CR
    Aesthet Surg J; 2020 Jun; 40(7):721-731. PubMed ID: 31761953
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Oncological Outcomes After Multidisciplinary Management of Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL).
    O'Connell RL; Sharma B; El-Sharkawi D; Wotherspoon A; Attygalle AD; MacNeill F; Khan AA; Tasoulis MK
    Ann Surg Oncol; 2023 Oct; 30(10):6170-6175. PubMed ID: 37454017
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Patient Registry and Outcomes for Breast Implants and Anaplastic Large Cell Lymphoma Etiology and Epidemiology (PROFILE): Initial Report of Findings, 2012-2018.
    McCarthy CM; Loyo-Berríos N; Qureshi AA; Mullen E; Gordillo G; Pusic AL; Ashar BS; Sommers K; Clemens MW
    Plast Reconstr Surg; 2019 Mar; 143(3S A Review of Breast Implant-Associated Anaplastic Large Cell Lymphoma):65S-73S. PubMed ID: 30817558
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Epidemiology of Breast Implant-Associated Anaplastic Large Cell Lymphoma in the United States: A Systematic Review.
    Santanelli di Pompeo F; Clemens MW; Paolini G; Firmani G; Panagiotakos D; Sorotos M
    Aesthet Surg J; 2023 Dec; 44(1):NP32-NP40. PubMed ID: 37616552
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.